Cite
HARVARD Citation
Herly, M. et al. (n.d.). AB0316 Patient's global assessment of general health by vas at baseline predicts ACR/EULAR remission after 3, 6 and 12 month's of efficient treatment in DMARD- and steroid naÏve early rheumatoid arthritis patients. The danish cimestra-study. Annals of the rheumatic diseases. p. 655. [Online].